These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24395718)

  • 21. Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.
    Ghosh P; Lee D; Kim KB; Stinchcomb AL
    Pharm Res; 2014 Jan; 31(1):148-59. PubMed ID: 23943543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.
    Milewski M; Yerramreddy TR; Ghosh P; Crooks PA; Stinchcomb AL
    J Control Release; 2010 Aug; 146(1):37-44. PubMed ID: 20678989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
    Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microneedle-Mediated Delivery of Copper Peptide Through Skin.
    Li H; Low YS; Chong HP; Zin MT; Lee CY; Li B; Leolukman M; Kang L
    Pharm Res; 2015 Aug; 32(8):2678-89. PubMed ID: 25690343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallic microneedles with interconnected porosity: A scalable platform for biosensing and drug delivery.
    Cahill EM; Keaveney S; Stuettgen V; Eberts P; Ramos-Luna P; Zhang N; Dangol M; O'Cearbhaill ED
    Acta Biomater; 2018 Oct; 80():401-411. PubMed ID: 30201432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
    Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
    Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles.
    Han T; Das DB
    J Pharm Sci; 2013 Oct; 102(10):3614-22. PubMed ID: 23873449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate.
    Kaur M; Ita KB; Popova IE; Parikh SJ; Bair DA
    Eur J Pharm Biopharm; 2014 Feb; 86(2):284-91. PubMed ID: 24176676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion.
    Brogden NK; Ghosh P; Hardi L; Crofford LJ; Stinchcomb AL
    J Pharm Sci; 2013 Jun; 102(6):1948-1956. PubMed ID: 23589356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of skin resealing after insertion of microneedles in human subjects.
    Gupta J; Gill HS; Andrews SN; Prausnitz MR
    J Control Release; 2011 Sep; 154(2):148-55. PubMed ID: 21640148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation through Microneedle-Treated Skin.
    Patel KK; Brogden NK
    Pharm Res; 2024 Feb; 41(2):355-363. PubMed ID: 38133717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diclofenac delays micropore closure following microneedle treatment in human subjects.
    Brogden NK; Milewski M; Ghosh P; Hardi L; Crofford LJ; Stinchcomb AL
    J Control Release; 2012 Oct; 163(2):220-9. PubMed ID: 22929967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric microneedles for controlled transdermal drug delivery.
    Singh P; Carrier A; Chen Y; Lin S; Wang J; Cui S; Zhang X
    J Control Release; 2019 Dec; 315():97-113. PubMed ID: 31644938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate.
    Bubić Pajić N; Vucen S; Ilić T; O'Mahony C; Dobričić V; Savić S
    Eur J Pharm Sci; 2021 Sep; 164():105895. PubMed ID: 34087357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.